Susquehanna International Group, LLP Scholar Rock Holding Corp Call Options Transaction History

Susquehanna International Group, LLP

9 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2024 Nov 14, 2024	SELL	$7.63 - $9.71 $21,364 - $27,188	-2,800 Reduced 2.03%	135,200 $1.08 Million
Q2 2024 Aug 15, 2024	BUY	$7.84 - $16.79 $793,408 - $1.7 Million	101,200 Added 275.0%	138,000 $1.15 Million
Q1 2024 May 07, 2024	SELL	$13.2 - $17.76 $439,560 - $591,408	-33,300 Reduced 47.5%	36,800 $653,000
Q4 2023 Feb 14, 2024	BUY	$6.52 - $20.32 $211,900 - $660,400	32,500 Added 86.44%	70,100 $1.32 Million
Q3 2023 Nov 14, 2023	BUY	$6.02 - $7.76 $128,225 - $165,288	21,300 Added 130.67%	37,600 $266,000
Q2 2023 Aug 11, 2023	SELL	$5.79 - $9.11 $1,737 - $2,733	-300 Reduced 1.81%	16,300 $122,000
Q1 2023 May 16, 2023	BUY	$7.36 - $12.72 $122,176 - $211,152	16,600 New	16,600 $132,000
Q2 2022 Aug 15, 2022	SELL	$4.66 - $13.96 $34,018 - $101,908	-7,300 Reduced 34.43%	13,900 $76,000
Q1 2022 May 16, 2022	BUY	$11.89 - $24.68 $252,068 - $523,216	21,200 New	21,200 $273,000

175

75.6M

585K

862K

Ticker SRRK
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 51,640,600
Market Cap $2.35B
Description
Scholar Rock Holding Corporation, a biopharmaceutical company, focuses on the discovery and development of medicines for the treatment of serious diseases in which signaling by protein growth factors plays a fundamental role. The company develops Apitegromab, an inhibitor of the activation of latent myostatin that has completed the Phase 3 clini...

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

Stay updated on Susquehanna International Group, LLP with notifications on news.